Can AI speed up the development of new drugs? Oracle and AstraZeneca think so
Oracle and AstraZeneca have announced a collaboration to use AI and real-world health data to optimize clinical trials.
Related stories
Amadeus, Cegid and Datadog compare views on AI in production
At the Datadog Summit in Paris, representatives of Amadeus, Cegid and Datadog briefly compared their experiences of running AI in production.
Pigment raises $250 million
Pigment has raised $250 million from EQT and other investors at a $2.3 billion valuation. The money will speed up work on Graphite and its AI agents.
OpenAI invests in a startup that uses brain implants to detect cancer
OpenAI has invested in a startup that uses brain implants to detect cancer. Wired describes it as the latest in a growing series of bets by AI companies on brain data.
OpenAI models are coming to Google Cloud
OpenAI and Google Cloud are bringing OpenAI's frontier models and Codex workflows to Gemini's Model Garden, available through the Google Cloud Marketplace. The move gives companies already working with Google Cloud a direct route to OpenAI's models.
Why Amazon plans to invest €16 billion in Germany in 2027
Amazon has announced plans to invest more than €16 billion in Germany in 2027. The money will go notably to its Amazon Leo satellite internet network and to data centers and AI, announced at a Berlin summit aimed at attracting international companies.